Abiopharma

🔍 ORR R DOUGLAS (Executive)

Company: FirstCash Holdings, Inc. (FCFS)

Report Date: 2026-08-17

Detailed Transactions and Holdings:

• Sold 1,000 shares of Common Stock at $215.98 per share (Direct)
  Date: 2026-08-17 | Code: S | equity_swap_involved: 0 | shares_owned_after: 95,789.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 1,000 shares of Common Stock at $216.04 per share (Direct)
  Date: 2026-08-17 | Code: S | equity_swap_involved: 0 | shares_owned_after: 40,610.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 1,000 shares of Common Stock at $215.97 per share (Direct)
  Date: 2026-08-17 | Code: S | equity_swap_involved: 0 | shares_owned_after: 34,734.00 | transaction_form_type: 4 | Footnotes: F1, F3

Footnotes:

• F1: Sale is pursuant to a 10b5-1 Preset Diversification Programs dated June 2, 2025 of which 9,000 shares, in aggregate, of FirstCash Holdings, Inc. common stock remain available for sale subject to certain timing conditions and minimum price thresholds.
• F2: The reported securities are held by a trust for the reporting person's spouse and her descendants (the "Spousal Trust"). The reporting person's spouse is trustee of the Spousal Trust.
• F3: The reported securities are held by a family limited partnership. The reporting person is the general partner of the partnership that owns the reported securities. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.